Product Information
TIAGABINE HCL 12 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $6.6399 per EA under NDC 00093807256. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Sep 30, 1997. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
12 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093807256
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
TIAGABINE HYDROCHLORIDEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020646FDA Approved
9/30/1997
TE Code
AB
On Market Since
3/9/2018
Pharmacological Classes
Price Statistics
The NADAC for TIAGABINE HCL 12 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 30.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.6399 per EA |
|---|---|
| All-time high | $6.6399 (Aug 19, 2026) |
| All-time low | $4.5146 (Nov 19, 2025) |
| 52-week high | $6.6399 |
| 52-week low | $4.5146 |
| Median price | $5.3386 |
| Average price | $5.4083 |
| Largest weekly change | +33.4% (Feb 18, 2026) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TIAGABINE HCL 12 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for TIAGABINE HCL 12 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $6.6399 per EA (NDC 00093807256), effective Aug 19, 2026.
How has the price of TIAGABINE HCL 12 MG TABLET changed over time?
Over the history we have for it, the NADAC for TIAGABINE HCL 12 MG TABLET has risen 30.9%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for TIAGABINE HCL 12 MG TABLET?
Since Apr 17, 2024, the NADAC for TIAGABINE HCL 12 MG TABLET has ranged from a low of $4.5146 (Nov 19, 2025) to a high of $6.6399 (Aug 19, 2026), with a median of $5.3386 per EA.
Are there cheaper alternatives to TIAGABINE HCL 12 MG TABLET?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TIAGABINE HCL 12 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures TIAGABINE HCL 12 MG TABLET?
TIAGABINE HCL 12 MG TABLET (NDC 00093807256) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.